Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2026 12:58 ET | Source: Spherix Global Insights

Physicians and Patients Agree Lupus Care Is Improving, But Both Say Meaningful Gaps Remain

Exton, PA, July 07, 2026 (GLOBE NEWSWIRE) -- While the treatment landscape for systemic lupus erythematosus (SLE) continues to evolve with increasing biologic adoption and a growing pipeline of...
July 07, 2026 09:42 ET | Source: BCC Research LLC

Chronic Kidney Disease Market to Reach $131.4 Billion by 2030, Driven by Rising Prevalence and Healthcare Infrastructure Investment

Examines the evolving competitive landscape, regulatory developments & investment trends shaping the future of chronic kidney disease management worldwide.
July 06, 2026 07:35 ET | Source: Research and Markets

Fair-Market Value Rates Revealed in New US Rheumatology Thought Leader Compensation Report

Dublin, July 06, 2026 (GLOBE NEWSWIRE) -- The "Fair-Market Value Compensation Rates for Rheumatology KOLs - United States" has been added to ResearchAndMarkets.com's offering. The Thought...
June 17, 2026 11:15 ET | Source: Spherix Global Insights

CTD-ILD Enters New Treatment Era, but Physicians Still See Significant Unmet Need

Exton, PA, June 17, 2026 (GLOBE NEWSWIRE) -- Despite the introduction of new therapies, connective tissue disease-associated interstitial lung disease (CTD-ILD) remains an area of significant unmet...
June 11, 2026 10:37 ET | Source: Research and Markets

Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition

Dublin, June 11, 2026 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2019-2026" report has been added to ResearchAndMarkets.com's offering. Antibody therapeutics carried...
June 08, 2026 07:00 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

KT-579 demonstrated consistent disease-modifying activity comparable or superior to approved and clinically active therapies in multiple preclinical lupus models KT-579 Phase 1 healthy volunteer...
May 26, 2026 04:00 ET | Source: AKAMPION

MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board

• Rheumatology expert Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of MetrioPharm AG.
May 26, 2026 04:00 ET | Source: AKAMPION

MetrioPharm AG: Prof. Dr. med. Jürgen Braun wird neues Mitglied des wissenschaftlichen Beirats

Der renommierte Rheumatologe Prof. Dr. med. Jürgen Braun tritt dem wissenschaftlichen Beirat (Scientific Advisory Board) der MetrioPharm AG bei.
March 03, 2026 08:00 ET | Source: Fort Wayne Rheumatology and Infusion

Fort Wayne Rheumatologists Monica Reddy, Karen Ringwald and Anil Rao Open Fort Wayne Rheumatology and Infusion

Fort Wayne Rheumatologists Monica Reddy, Karen Ringwald and Anil Rao Open Fort Wayne Rheumatology and Infusion
February 24, 2026 07:03 ET | Source: Research and Markets

Inflammatory Bowel Disease Treatment Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Launches, Sustainability Goals, Revenue Insights

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease Treatment Market Company Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights,...